# FDA 483 - KP Pharmaceutical Technology - March 11, 2024

Source: https://www.keypedia.com/records/483/kp-pharmaceutical-technology/173fdef4-ac0a-4d24-b45a-3209f2cd0614

> FDA 483 for KP Pharmaceutical Technology on March 11, 2024. Product: Drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: KP Pharmaceutical Technology
- Inspection Date: 2024-03-11
- Product Type: Drugs
- Office Name: Detroit District Office
- Summary: A concise summary of the FDA 483 document could not be generated as the provided content was blank or unreadable. Therefore, details such as the company name, inspection dates, main violations or issues, regulatory framework, and required actions could not be extracted or included in this summary.

## Related Documents

- [483 - 2023-02-03](https://www.keypedia.com/records/483/kp-pharmaceutical-technology/af93ffc6-90c2-4cba-8eba-f8fa21b7a395)
- [483 - 2024-03-21](https://www.keypedia.com/records/483/kp-pharmaceutical-technology/c774dd17-c5c5-4769-9d75-e5911bfefd41)

## Related Officers

- [President and CEO](https://www.keypedia.com/people/rajinder-p-mathura/06f10169-a154-46c8-98fb-89864ef07127)
- [Travis V. Hull](https://www.keypedia.com/people/travis-v-hull/1f3b5843-29ed-4291-8a8a-a2bf3ac36988)
- [Investigator?](https://www.keypedia.com/people/robert-j-ham/9146e819-4fce-420c-a722-cbe14e3c6afb)
- [Investigator](https://www.keypedia.com/people/rafeeq-a-habeeb/ac58c0b7-bd42-4037-8ccb-bf0351b7744f)

Company: https://www.keypedia.com/companies/kp-pharmaceutical-technology/acd7d203-2bd2-4702-a902-83c45f57890f

Office: https://www.keypedia.com/offices/detroit-district-office/b09a1815-a000-40c0-bb44-5432ce87ed03